142 related articles for article (PubMed ID: 32243308)
1. Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Egemen D; Cheung LC; Chen X; Demarco M; Perkins RB; Kinney W; Poitras N; Befano B; Locke A; Guido RS; Wiser AL; Gage JC; Katki HA; Wentzensen N; Castle PE; Schiffman M; Lorey TS
J Low Genit Tract Dis; 2020 Apr; 24(2):132-143. PubMed ID: 32243308
[TBL] [Abstract][Full Text] [Related]
2. 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.
Cheung LC; Egemen D; Chen X; Katki HA; Demarco M; Wiser AL; Perkins RB; Guido RS; Wentzensen N; Schiffman M
J Low Genit Tract Dis; 2020 Apr; 24(2):90-101. PubMed ID: 32243306
[TBL] [Abstract][Full Text] [Related]
3. A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Demarco M; Egemen D; Raine-Bennett TR; Cheung LC; Befano B; Poitras NE; Lorey TS; Chen X; Gage JC; Castle PE; Wentzensen N; Perkins RB; Guido RS; Schiffman M
J Low Genit Tract Dis; 2020 Apr; 24(2):144-147. PubMed ID: 32243309
[TBL] [Abstract][Full Text] [Related]
4. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
5. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
6. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
[TBL] [Abstract][Full Text] [Related]
7. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Massad LS; Einstein MH; Huh WK; Katki HA; Kinney WK; Schiffman M; Solomon D; Wentzensen N; Lawson HW;
Obstet Gynecol; 2013 Apr; 121(4):829-846. PubMed ID: 23635684
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
Katki HA; Kinney WK; Fetterman B; Lorey T; Poitras NE; Cheung L; Demuth F; Schiffman M; Wacholder S; Castle PE
Lancet Oncol; 2011 Jul; 12(7):663-72. PubMed ID: 21684207
[TBL] [Abstract][Full Text] [Related]
9. 2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023.
Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
J Low Genit Tract Dis; 2024 Jan; 28(1):3-6. PubMed ID: 38117563
[TBL] [Abstract][Full Text] [Related]
10. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Massad LS; Einstein MH; Huh WK; Katki HA; Kinney WK; Schiffman M; Solomon D; Wentzensen N; Lawson HW;
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S1-S27. PubMed ID: 23519301
[TBL] [Abstract][Full Text] [Related]
11. Assessing Physician Adherence to Guidelines for Cervical Cancer Screening and Management of Abnormal Screening Results.
Min CJ; Massad LS; Dick R; Powell MA; Kuroki LM
J Low Genit Tract Dis; 2020 Oct; 24(4):337-342. PubMed ID: 32976292
[TBL] [Abstract][Full Text] [Related]
12. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of Tests for Postcolposcopy and Posttreatment Surveillance.
Clarke MA; Unger ER; Zuna R; Nelson E; Darragh TM; Cremer M; Stockdale CK; Einstein MH; Wentzensen N
J Low Genit Tract Dis; 2020 Apr; 24(2):148-156. PubMed ID: 32243310
[TBL] [Abstract][Full Text] [Related]
14. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.
Leinonen MK; Nieminen P; Lönnberg S; Malila N; Hakama M; Pokhrel A; Laurila P; Tarkkanen J; Anttila A
BMJ; 2012 Nov; 345():e7789. PubMed ID: 23197596
[TBL] [Abstract][Full Text] [Related]
15. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
J Low Genit Tract Dis; 2020 Apr; 24(2):102-131. PubMed ID: 32243307
[No Abstract] [Full Text] [Related]
16. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
[TBL] [Abstract][Full Text] [Related]
17. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
[TBL] [Abstract][Full Text] [Related]
18. Making Sense of Cervical Cancer Screening Guidelines and Recommendations.
Davis M; Feldman S
Curr Treat Options Oncol; 2015 Dec; 16(12):55. PubMed ID: 26467929
[TBL] [Abstract][Full Text] [Related]
19. Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force.
Kim JJ; Burger EA; Regan C; Sy S
JAMA; 2018 Aug; 320(7):706-714. PubMed ID: 30140882
[TBL] [Abstract][Full Text] [Related]
20. Risk-Based Cervical Consensus Guidelines: Methods to Determine Management if Less Than 5 Years of Data Are Available.
Egemen D; Perkins RB; Clarke MA; Guido R; Huh W; Saraiya M; Saslow D; Smith R; Unger ER; Garcia F; Wentzensen N; Cheung LC;
J Low Genit Tract Dis; 2022 Jul; 26(3):195-201. PubMed ID: 35763610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
